Alset Inc. AEI Biohealth Business — Nonoperating Income Expense

Other segment segments

Similar metrics at other companies

ANABBiopharma Company — Nonoperating Income Expense

$2.33M-43.0%

LODEBioleum — Nonoperating Income Expense

-$30.95K+59.9%

ANABBiopharma Company — Other Nonoperating Income Expense

-$1K+85.7%

PFEBiopharma — Other Nonoperating Income (Expense)

$116M+48.7%

VAN

VANIBiopharm Division — Other Nonoperating Income Expense

-$209K+29.4%

ANNXInterest And Other Non Operating Income Expense

$1.91M-37.3%

Questions, answered.

What is Alset Inc.'s biohealth business — nonoperating income expense?

Alset Inc. (AEI) reported biohealth business — nonoperating income expense of -$6.26K in Q1 2026.

How has Alset Inc.'s biohealth business — nonoperating income expense changed year-over-year?

Alset Inc.'s biohealth business — nonoperating income expense increased by 99.1% year-over-year, from -$698.37K to -$6.26K.

What is the long-term trend for Alset Inc.'s biohealth business — nonoperating income expense?

Over 2 years (2021 to 2023), Alset Inc.'s biohealth business — nonoperating income expense has grown at a -87.7% compound annual growth rate (CAGR), from -$39.27M to -$593.99K.

What does biohealth business — nonoperating income expense mean?

Captures financial impacts from activities outside the primary biohealth business operations, such as interest income, interest expense, or gains/losses on investments. This metric helps investors distinguish between core operational success and peripheral financial events.